PATENT CLAIM ANALYSIS

Application Number: 16025624
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to attenuated, immunogenic  West Nile virus  chimeras built on a  dengue virus  backbone for the production of immunogenic, live, attenuated  West Nile virus  vaccines.

Claim (Index 15):
An immunogenic composition comprising one or more than one nucleic acid chimera of  claim 1  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.33333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14305572', '10871775', '13406153', '12990322', '11912482']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8064714571627253
- 35 USC 102 Novelty (BERT): 0.6310943837914623
- Combined Prediction Score: 0.788933749825599
- Mean Citation Score: 508.6713820000001
- Max Citation Score: 629.3731
- Similarity Product: 547.8843441939831

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test